Bio Developments

(Image: Getty/Manjural)

The journey to an approved Ebola vaccine

By Ben Hargreaves

Europe approved the first vaccine for the Ebola virus, but the path to reach this point has taken many years and required a global effort.

(Image: Getty/LightFieldStudios)

Amgen joins neuroscience exodus

By Ben Hargreaves

In third quarter financials, Amgen announces that it will end its R&D efforts in neuroscience to focus on diseases with a ‘large public health impact.

(Image: Getty/maxsattana)

GE Healthcare sets up UK biotech R&D lab

By Vassia Barba

GE Healthcare opens lab space to provide developers with access to protein and cell analysis technologies to encourage networking and partnering on R&D services.

Follow us


View more